Fintech PR
Luzerner Kantonalbank AG implements FM Converge from Finmechanics for its Cloud-based Front-Office, Pricing and Risk Infrastructure
LONDON and LUCERNE, Switzerland, Feb. 12, 2024 /PRNewswire/ — Luzerner Kantonalbank AG (LUKB), Switzerland’s 3rd largest cantonal bank, has rolled out FM Converge, the next generation markets and risk platform for banks and financial institutions. FM Converge comes from Finmechanics Pte. Ltd., the Singapore headquartered fast growing software company. FM Converge is a high performant cross-asset front to back platform that enables banks to run their markets business on a private or public cloud. Built on a services-based architecture, the platform enables short time-to-market for new products, manages compliance with new regulations quickly and handles growth in client flow of vanilla and structured products in a seamless way.
“By integrating FM Converge into LUKB’s infrastructure, we were able to provide full cross asset pricing and risk capabilities with a very low technology footprint”, says Anindya Sarkar, CEO of Finmechanics. “This project brings together our experience from large Asia Pacific and Global banks, our SaaS capabilities and highly responsive local support. I extend my sincere thanks to LUKB for the trust in us and our product and the great collaboration throughout the whole project. We remain committed to supporting our client beyond the platform’s implementation, ensuring that navigating evolving financial management needs are continually met with excellence and dedication.”
Daniel Bommer, Head of Trading ＆ Treasury Services of LUKB says:
“With the implementation of FM Converge, we were able to successfully replace the long-standing system for position management and risk management in the trading book. Finmechanics clearly prevailed against a strong field of providers in the extensive tendering process. In addition to the best price/performance ratio, we were particularly impressed by the interaction with the provider, who was very professional, reliable and fast.
FM Converge offers LUKB future-proof trading software that covers all the functions required for pricing, trading and risk management across all asset classes. With FM Converge, we have implemented a state-of-the-art infrastructure that enables our targeted growth in the trading business and at the same time fulfils all existing and future regulatory requirements. Finmechanics proved to be a competent, agile and innovative partner during the project and we look forward to tackling future challenges in the trading sector together with Finmechanics.”
FM Converge has been deployed on the cloud in a SaaS (Software as a Service) model to address the Pricing and Risk requirements of all asset classes including Crypto. High speed full-revaluation computations of VaR, sensitivity and various risk measures for all trade types, has enabled the bank to actively manage real time financial risk arising out of its markets operations and client trades. Going forward, cross-asset structured products, additional market and credit risk modules (such as SA-CCR and FRTB) and Collateral Management shall be rolled out providing the bank with a comprehensive coverage for both current and upcoming regulations.
A fully hosted and managed environment makes the FM Converge installation highly scalable and responsive to fluctuating demand, significantly reducing operational and maintenance cost.
About Finmechanics
Headquartered in Singapore with offices in 7 countries, Finmechanics provides banks with high precision and transparency in valuations, risk management and regulatory compliance, as well as end-to-end digitized trade workflows. The Finmechanics Microservices inspired approach help firms to simplify and transform their organisation, defining new standards of efficiency and be truly Cloud ready for the markets business.
To learn more about Finmechanics products, technology, and integration services, please visit https://www.finmechanics.com.
About Luzerner Kantonalbank AG
Founded in 1850, Luzerner Kantonalbank AG (LUKB) is the leading bank in Canton Lucerne. With some 1,300 staff, it maintains a network of 23 branches and is one of the largest cantonal banks in Switzerland. Its core business areas include real estate and business financing, pension provision, and asset advisory and management. The Bank is known for its closeness to its clients and its outstanding service, making it the first choice for clients, staff, shareholders, and the local region.
The LUKB Group comprises two wholly owned subsidiaries: the fund management company LUKB Expert Fondsleitung AG and Refinum AG. LUKB has been a joint-stock company under private law since 2001 and is listed on SIX Swiss Exchange. It has a free float of 38.5 % of share capital, while the remaining 61.5 % of shares are held by the Canton of Lucerne.
LUKB has a state guarantee, and a long-term AA credit rating from Standard & Poor’s (short-term rating of A-1+).
To learn more about Luzerner Kantonalbank AG visit the English window of the website: https://www.lukb.ch/de/ueber-uns/english-window
View original content:https://www.prnewswire.co.uk/news-releases/luzerner-kantonalbank-ag-implements-fm-converge-from-finmechanics-for-its-cloud-based-front-office-pricing-and-risk-infrastructure-302057466.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News6 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News6 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News5 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system
-
Latest News6 days ago
Report Finds that Huawei DigiTruck Training Helps Boost Income, Employment and Entrepreneurship
-
Latest News2 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News2 days ago
Lunar Poised for Nationwide Rollout in Sweden After Securing €24.1 Million in Funding
-
Latest News5 days ago
SAR1.1 Billion Riyadh Real Estate Fund Launched by Ezdihar Real Estate Development & Al-Istithmar Capital